Clinical Trial Update: Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis

View source ↗

Summary

Clinical trial update describing the effect of fingolimod on cardiac autonomic regulation in patients with relapsing-remitting multiple sclerosis, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GILENYA (FINGOLIMOD HCL)

Snippet

Sponsor: Kuopio University Hospital | Conditions: Relapse-remitting Multiple Sclerosis | Status: COMPLETED